FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/02/104317 [Registered on: 19/02/2026] Trial Registered Prospectively
Last Modified On: 18/02/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Randomized Trial in Liver Donors Comparing Upper Midline and Pfannenstiel Cuts for liver Removal After Robotic Liver Donation to compare Pain , cosmesis and quality of life. 
Scientific Title of Study   Randomized control trial on graft retrieval via upper midline incision vs Pfannenstiel incision following Modified robotic donor hepatectomy 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Akshay Brara 
Designation  Senior Resident 
Affiliation  Max Super Specialty Hospital 
Address  Room no- CLBS office, fifth floor, west block, Max Super Specialty Hospital, 1 , Press Enclave Marg, Saket Institutional Area, South DELHI- 110017 India

South
DELHI
110017
India 
Phone  8197666567  
Fax    
Email  akshaybrara@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr S Sreejith 
Designation  Senior Consultant 
Affiliation  Max Super Specialty Hospital 
Address  Room no- CLBS office, fifth floor, west block, Max Super Specialty Hospital, 1 , Press Enclave Marg, Saket Institutional Area, South DELHI- 110017 India

South
DELHI
110017
India 
Phone  9946357466  
Fax    
Email  drssreejith@gmail.com   
 
Details of Contact Person
Public Query
 
Name  Dr Akshay Brara 
Designation  Senior Resident 
Affiliation  Max Super Specialty Hospital 
Address  Room no- CLBS office, fifth floor, west block, Max Super Specialty Hospital, 1 , Press Enclave Marg, Saket Institutional Area, South DELHI- 110017 India

South
DELHI
110017
India 
Phone  8197666567  
Fax    
Email  akshaybrara@gmail.com  
 
Source of Monetary or Material Support  
NIL 
 
Primary Sponsor  
Name  Max Super Specialty Hospital 
Address  Room no- CLBS office, fifth floor, west block, Max Super Specialty Hospital, 1 , Press Enclave Marg, Saket Institutional Area, South, DELHI 110017, India 
Type of Sponsor  Private hospital/clinic 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Akshay Brara  Max Super Specialty Hospital  CLBS office 5th floor West Wing Max Super Specialty Hospital 1 2 Press Enclave, Saket, New Delhi, Delhi-110017
South
DELHI 
8197666567

akshaybrara@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Max Healthcare Ethics Committee   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Healthy liver donors 
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Pfannenstiel Incision (PFI)   Low transverse incision for graft retrieval after modified robotic donor hepatectomy  
Comparator Agent  Upper Midline Incision (UMI)   Upper midline incision for graft retrieval after modified robotic donor hepatectomy  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1. Age 18 to 65 years.
2. Medically cleared for minimally invasive donor hepatectomy
3. Provided written informed consent 
 
ExclusionCriteria 
Details  1. Prior abdominal surgeries precluding assigned incision.
2. Any other contraindications to laparoscopic/robotic surgery.
3. Refusal to participate or higher cost.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
i. Chart of Visual Analogue Scale (VAS) at 6, 24, 48, 72, 96, 120hours (DAY0-DAY5).
ii. Donor quality of life estimated by WHOQOL-BREF Score at 1 month, 3 months, 6 months and 12 months
 
18 months 
 
Secondary Outcome  
Outcome  TimePoints 
i. Wound complications (infection, hematoma, dehiscence).
ii. Cosmesis by POSAS score.
iii. Cost of procedure.
iv. Hospital stay (days).
v. Re-exploration / percutaneous intervention for hemorrhage, biliary or vascular issues.
vi. Graft function (peak AST, ALT, bilirubin)
vii. Warm ischemia time (intraoperative).
 
24 months 
 
Target Sample Size   Total Sample Size="210"
Sample Size from India="210" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   02/03/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Minimally invasive donor hepatectomy (MIDH) has become increasingly popular due to its demonstrated benefits of decreased postoperative morbidity and faster recovery relative to open techniques. Among minimally invasive methods, robotic donor hepatectomy offers unparalleled surgical control, allowing meticulous dissection of critical structures such as the hepatic artery, portal vein, and biliary ducts with enhanced precision and safety.

 

While the intra-abdominal phase has been extensively optimized through robotic systems, graft retrieval still necessitates a mini-laparotomy incision. The upper midline incision provides excellent operative exposure and is standard in many Asian centers. Conversely, the Pfannenstiel incision, located transversely in the lower abdomen, offers cosmetic and respiratory advantages by preserving upper abdominal musculature.

Thus, this study aims to evaluate donor postoperative pain, quality of life, wound complications, cosmetic outcomes, procedural costs, hospital stay, and graft function between UMI and PFI after modified robotic donor hepatectomy, providing evidence-based recommendations for optimal graft retrieval incision selection in modern minimally invasive liver transplantation practice.

 
Close